Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (561-570 of 663) with videos related to

Pageof 67
Sort By:
American Heart Journal|March 12, 2022
Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortiumMuhammad Zubair Israr, Hong Zhan, Andrea Salzano, et al.
Circulation. Heart Failure|November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) StudyJohn G Cleland, Karen Chiswell, John R Teerlink, et al.
European Journal of Heart Failure|May 17, 2021
Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrumVasiliki Bistola, Panagiotis Simitsis, John Parissis, et al.
BMJ Open|March 5, 2018
An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictorsJohannes M I H Gho, Amand F Schmidt, Laura Pasea, et al.
European Journal of Heart Failure|October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
International Journal of Cardiology|July 26, 2016
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of lifeTarek Bekfani, Pierpaolo Pellicori, Daniel A Morris, et al.
European Journal of Clinical Nutrition|October 31, 2013
U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgeryR G Metcalf, G V Skuladottir, O S Indridason, et al.
International Journal of Cardiology|February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
European Journal of Internal Medicine|November 12, 2019
Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHFMasatake Kobayashi, Adriaan A Voors, Nicolas Girerd, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
Pageof 67

Showing results (561-570 of 663) with videos related to

Sort By:
Pageof 67
American Heart Journal|March 12, 2022
Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortiumMuhammad Zubair Israr, Hong Zhan, Andrea Salzano, et al.
Circulation. Heart Failure|November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) StudyJohn G Cleland, Karen Chiswell, John R Teerlink, et al.
European Journal of Heart Failure|May 17, 2021
Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrumVasiliki Bistola, Panagiotis Simitsis, John Parissis, et al.
BMJ Open|March 5, 2018
An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictorsJohannes M I H Gho, Amand F Schmidt, Laura Pasea, et al.
European Journal of Heart Failure|October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
International Journal of Cardiology|July 26, 2016
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of lifeTarek Bekfani, Pierpaolo Pellicori, Daniel A Morris, et al.
European Journal of Clinical Nutrition|October 31, 2013
U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgeryR G Metcalf, G V Skuladottir, O S Indridason, et al.
International Journal of Cardiology|February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
European Journal of Internal Medicine|November 12, 2019
Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHFMasatake Kobayashi, Adriaan A Voors, Nicolas Girerd, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
Pageof 67